Literature DB >> 8203369

Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis.

N Matsuyama1, K Joh, Y Yamaguchi, S Aizawa, T Kanai, T Kitajima, O Sakai.   

Abstract

We report a case of a 40-year-old woman with benign monoclonal gammopathy who developed focal segmental glomerulosclerosis associated with widespread deposition of large crystalline inclusions in the glomerular podocytes. Electron microscopy showed that the crystalline structures were electron dense and needle shaped or polygonal. At a higher magnification, they were seen to be surrounded by unit membranes and to feature a longitudinal filamentous substructure. These inclusions showed positive immunohistochemical staining for kappa light chain. Clinically, the patient had shown nephrotic syndrome on the first medical examination, and later revealed chronic renal failure and monoclonal gammopathy of the immunoglobulin G kappa type, but no evidence of multiple myeloma or other lymphoproliferative diseases. This patient seems to have had a rare form of glomerular involvement associated with benign monoclonal gammopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203369     DOI: 10.1016/s0272-6386(12)80141-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  [Lupus nephritis with crystal structures in glomerulopathy ].

Authors:  M Otto; T Hansen; S Bertz; E H Strøm; S H Brorson; M J Mihatsch; J Kriegsmann
Journal:  Pathologe       Date:  2003-10       Impact factor: 1.011

2.  Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS).

Authors:  Mahesha Vankalakunti; Ravishankar Bonu; Shilpa Shetty; Vishwanath Siddini; Kishore Babu; Sudarshan H Ballal
Journal:  Clin Kidney J       Date:  2014-03-18

3.  Multiple myeloma with a previous diagnosis of focal segmental glomerulosclerosis: A case report and review of the literature.

Authors:  Zhe-Yi Dong; Hai-Tao Xing; Yuan-DA Wang; Wei Zhang; Qiang Qiu; Xiang-Mei Chen
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

Review 4.  Monoclonal Gammopathy of Renal Significance-A Rare Renal Presentation: A Review of Cases Reported.

Authors:  Asim Kichloo; Najma Nawaz; Jagmeet Singh; Michael Aljadah; Michael Stanley Albosta; Ravinder Bhanot
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

5.  Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report.

Authors:  Rajib K Gupta; Lois J Arend; Anupama Bk; Sriram Narsipur; Ramya Bhargava
Journal:  BMC Nephrol       Date:  2020-05-18       Impact factor: 2.388

Review 6.  Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.

Authors:  Xiao-Juan Yu; Xu-Jie Zhou; Su-Xia Wang; Fu-de Zhou; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2018-11-12       Impact factor: 2.388

7.  Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report.

Authors:  You La Jeon; Woo In Lee; Yujin Choi; So Young Kang; Myeong Hee Kim; Sung-Jig Lim; Sang Ho Lee
Journal:  Diagn Pathol       Date:  2015-12-16       Impact factor: 2.644

8.  Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma.

Authors:  Eun Jeong Lee; Su Yeon Lee; So Young Park; Yonjin Kim; Jae Shin Choi; Mi Jeoung Kim; Ji Hyeon Park; Jung Eun Lee; Ghee Young Kwon; Yoon-Goo Kim
Journal:  Kidney Res Clin Pract       Date:  2016-06-18

9.  A case report of crystalline light chain inclusion-associated kidney disease affecting podocytes but without Fanconi syndrome: A clonal analysis of pathological monoclonal light chain.

Authors:  Kiyoaki Ito; Satoshi Hara; Kazunori Yamada; Takeshi Zoshima; Ichiro Mizushima; Hiroshi Fujii; Ryoichi Miyazaki; Yasukazu Kawai; Akihiro Yachie; Michio Nagata; Shozo Izui; Masakazu Yamagishi; Mitsuhiro Kawano
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.